T-acute Lymphoblastic Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-10-31
Clinical Trial Update: BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma [Phase 2]
Phase 2 trial investigating BL-8040 with nelarabine for relapsed/refractory T-ALL and T-ALL/LBL was terminated; results posted.